Nobumasa Kobayashi
Tokai University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nobumasa Kobayashi.
Leukemia Research | 1996
Hiroshi Kawada; Ryuki Fukuda; Miyoko Yoshida; Mieko Takei; Nobumasa Kobayashi; Akira Masumoto; Yoshiaki Ogawa; Tamotsu Sasao; Nobuyuki Kubota; Shigeki Watanabe; Yoshikatsu Umeda; Kunihiko Yamauchi; Shuji Yonekura; Yukinobu Ichikawa
In this study, we examined expressions of several adhesion molecules (AdMs), i.e. leukocyte function antigen-1 (LFA-1: CD11a/CD18), Hermes homing receptor (CD44) and intercellular adhesion molecule-1 (ICAM-1: CD54), on leukemia cells from 51 adult patients with newly diagnosed acute myeloid leukemias (AMLs) to elucidate clinical significance of these AdM expressions. Those expressions in lymphoid malignancies have been correlated with tumor evolutions, but CD44 was detected in all the AML cases examined and CD54 expression did not associate with their clinical characteristics or outcomes. However, we found that LFA-1 expressions significantly correlated with splenomegaly, resistance to induction chemotherapies and short survival periods in AML patients.
Lupus | 1992
Yukinobu Ichikawa; Kazunaga Takamatsu; Hiroaki Shimizu; Mitsuaki Uchiyama; Junko Moriuchi; Masatoshi Takaya; Nobumasa Kobayashi; Tsutomu Kawada; Shigeru Arimori
Anticardiolipin antibodies (aCL) were recently discovered to recognize a complex consisting of phospholipids and apolipoprotein H (apo H). In this study, we determined the serum apo H levels in 36 systemic lupus erythematosus (SLE) patients with or without antiphospholipid antibodies (aPL), including aCL and lupus anticoagulants, to clarify the possible effects of aPL on apo H levels in vivo. The apo H levels were low in SLE patients as compared with 22 healthy controls. However, no associations were found between apo H levels and circulating aPL or clinical features of the antiphospholipid antibody syndrome. A secondary hyperlipidemic state, which probably related to lupus nephritis (proteinuria) and/or prednisolone treatment, increased apo H levels in SLE patients.
Japanese Journal of Cancer Research | 1991
Yoshihiko Nakamura; Takashi Nishimura; Yutaka Tokuda; Nobumasa Kobayashi; Katsuto Watanabe; Takashi Noto; Toshio Mitomi; Kazuo Sugamura; Sonoko Habu
Fresh human CD8+ T cells showed a strong proliferative response to a high concentration of interleukin 2 (IL–2) in the absence of macrophages. In contrast, CD4+ T cells revealed no significant IL–2 responsiveness in the absence of macrophages. However, if CD4+ T cells were cocultured with macrophages, they showed higher proliferative response to IL–2 than CD8+ T cells. In accordance with the magnitude of IL–2 responsiveness, freshly isolated CD8+ T cells expressed significant amounts of p75 IL–2 receptor, while fresh CD4+ T cells did not express p75 IL–2 receptor. The expression of p75 IL–2 receptor on CD4+ T cells was induced by coculture with macrophages. The macrophage–induced p75 IL–2 receptor acquisition was blocked by monoclonal antibody (inAh) against class II antigen. Moreover, the addition of anti–CD4 mAb or anti–class II mAb to the culture caused a great inhibition of IL–2 responsiveness of CD4+ T cells. These results strongly suggest that macrophage–T cell interaction through CD4 and/or class II molecules is essential for the expression of p75 IL–2 receptor and IL–2 responsiveness in human CD4+, but not CD8+ T cells.
Acta Haematologica | 1994
Hiroshi Kawada; Shigeki Watanabe; Miyoko Yoshida; Ryuki Fukuda; Nobumasa Kobayashi; Akira Masumoto; Yoshiaki Ogawa; Yoshiaki Ohbayashi; Shuji Yonekura; Yukinobu Ichikawa
Flow Cytometric Analysis of T-Cell-Rich B-Cell Lymphoma H. Hiroshi Kawada S. Shigeki Watanabe M. Miyoko Yoshida R. Ryuki Fukuda N. Nobumasa Kobayashi A. Akira Masumoto Y. Yoshiaki Ogawa Y. Yoshiaki Ohbayashi S. Shuji Yonekura Y. Yukinobu Ichikawa Fourth Department of Internal Medicine, Tokai University School of Medicine, and Blood Transfusion Center of Tokai University Hospital, Bohseidai, Isehara, Kanagawa, Japan
Acta Haematologica | 1994
Hiroshi Kawada; Yukinobu Ichikawa; Nobumasa Kobayashi; Ryuki Fukuda; Shuji Yonekura; Tadami Nagao
We herein report a case of acute myeloid leukaemia (AML, FAB:M0) who showed upregulation of T-lymphoid antigens (CD2, CD7) and adhesion molecules (CD11a, CD11b, CD18) on leukaemic cells after in vivo administration of granulocyte colony-stimulating factor (G-CSF). To our knowledge, this is the first report which describes in vivo changes of cell surface antigen expression on AML cells after the administration of G-CSF.
Journal of hematotherapy | 1994
Yoshihiko Nakamura; Mitsunori Noma; Masako Kidokoro; Nobumasa Kobayashi; Mieko Takei; Shiho Kurashima; Takehito Mukaiyama; Shunichi Kato
Internal Medicine | 1993
Hiroshi Kawada; Yukinobu Ichikawa; Nobumasa Kobayashi; Ryuki Fukuda; Shuji Yonekura; Tadami Nagao
Japanese Journal of Transfusion and Cell Therapy | 2011
Junichi Terauchi; Kazuyo Yagi; Shinichi Otani; Akira Ito; Shoichi Inaba; Nobumasa Kobayashi; Shunichi Kato; Kanagawa Prefectural Joint Meeting
Japanese Journal of Transfusion and Cell Therapy | 2017
Hitomi Yamaguchi; Tatsuya Sugimoto; Yumiko Maezawa; Tomomi Sakurai; Akifumi Koyama; Chie Nakashioya; Hiroyuki Itagaki; Mieko Takei; Fumiko Tsuchida; Nobumasa Kobayashi; Minoru Kojima; Fumiaki Yoshiba; Hiromasa Yabe
Journal of the Japan Society of Blood Transfusion | 1995
Yoshihiko Nakamura; Mitsunori Noma; Masako Kidokoro; Nobumasa Kobayashi; Mieko Takei; Noriko Matsumura; Osamu Hyodo; Sadaki Inokuchi; Takehito Mukaiyama; Shunichi Kato